Drug intelligence / Profile preview

Hydrocortisone + Prednisolone

Development stage
Unknown
Lead developer
Merck
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

The combination "hydrocortisone + prednisolone" refers to two separate corticosteroid medications that are sometimes used together or interchangeably in clinical practice. Both are glucocorticoids with anti-inflammatory properties, though they differ in potency, duration of action, and specific applications. ## Pharmacological Comparison Hydrocortisone has a 1:1 ratio for glucocorticoid (anti-inflammatory) and mineralocorticoid (water retention) properties, while prednisolone has a 4:0.8 ratio, making it more potent in terms of anti-inflammatory effects with less mineralocorticoid activity. In terms of potency, 5mg of oral prednisolone is generally considered equipotent to 20mg of oral or IV hydrocortisone, though some evidence suggests prednisolone may be six to eight times more potent than hydrocortisone at replacement doses. Regarding duration of action, prednisolone has a longer effect (18-36 hours) compared to hydrocortisone (8-12 hours). This difference in duration means hydrocortisone may need to be administered more frequently to maintain the same anti-inflammatory effect. ## Clinical Applications Both medications are used to treat various conditions including: - Inflammatory disorders - Allergic reactions - Autoimmune diseases - Adrenal insufficiency - Certain types of arthritis - Severe asthma For severe asthma, research has shown that intravenous hydrocortisone provides no additional benefit when given alongside oral prednisolone and bronchodilator therapy in patients admitted to hospital without ventilatory failure. When switching between these medications, care must be taken due to their different potencies and durations of action. Patients are typically switched from IV hydrocortisone to oral prednisolone as soon as possible, sometimes at a higher dose initially before weaning back to baseline.

02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on Hydrocortisone + Prednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydrocortisone + Prednisolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call